2018. Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S51. DOI:https://doi.org/10.25251/skin.2.supp.51.